About Us
Join us for an intensive two-day hands-on training workshop focused on leveraging high-resolution Nuclear Magnetic Resonance (NMR) spectroscopy for the characterization of higher-order structures (HoS) and aggregation states in biopharmaceuticals—critical quality attributes that directly impact therapeutic efficacy and safety.
Designed for industry professionals, this program offers a deep dive into:
-
NMR data acquisition and processing
-
Statistical analysis techniques
-
Interpretation strategies for therapeutic peptides and monoclonal antibodies (mAbs)
-
Expert Insights on Regulatory filings and Approvals
Program Overview
Training Outcomes
-
NMR data processing of 1D, 2D, and 2D-DOSY spectra
-
Principal Component Analysis (PCA) for demonstrating similarity between drug product & RLD
-
Sequence-specific peak assignments for understanding HoS and impurities
-
Interpretation of NMR data for biosimilarity between peptide drug product & RLD
-
Identify and characterize impurities in peptide drug substances and products using NMR
-
Gain deep insights into HoS through sequence-specific peak assignments
Software & Techniques
-
NMR data processing (1D, 2D, 2D-DOSY spectra)
-
Principal Component Analysis (PCA)
-
CcpNmr for sequence-specific peak assignment
-
MNova for data interpretation and visualization
Past Event
The Executive Hands-on Training Program on NMR Data Analysis and Interpretation brought together 20 executive-level participants from leading biopharma and pharma industries. The program provided an intensive, application-driven experience focused on advancing skills in NMR-based characterization of peptides and biologics.
Key Highlights:
-
Peptide aggregation
-
NMR Data Interpretation
-
Principal Component Analysis
-
High Order Structure
-
1D 2D
-
DOSY
Previous Speakers